Mikkel L. Ostergaard

Mikkel L. Ostergaard

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 479 publications

Correction: Clinical and MRI remission in axial spondyloarthritis: one-year outcomes and predictors from the TRACE treat-to-target study with secukinumab.

Correction: Clinical and MRI remission in axial spondyloarthritis: one-year outcomes and predictors from the TRACE treat-to-target study with secukinumab.

Journal: Arthritis research & therapy
Published: July 18, 2026

Spondyloarthritis Inception Cohort of Southern Denmark (SPINCODE): a protocol for a single centre prospective observational cohort study in patients suspected of axial spondyloarthritis.

Spondyloarthritis Inception Cohort of Southern Denmark (SPINCODE): a protocol for a single centre prospective observational cohort study in patients suspected of axial spondyloarthritis.

Journal: BMJ open
Published: July 01, 2026

The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients.

The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patients.

Journal: EULAR rheumatology open
Published: June 29, 2026

Feasibility of INSELMA: an interdisciplinary nurse-coordinated self-management intervention for people with inflammatory arthritis and substantial disease impact.

Feasibility of INSELMA: an interdisciplinary nurse-coordinated self-management intervention for people with inflammatory arthritis and substantial disease impact.

Journal: EULAR rheumatology open
Published: June 29, 2026

Differential joint-level response to secukinumab in psoriatic arthritis: A collaborative European observational cohort study.

Differential joint-level response to secukinumab in psoriatic arthritis: A collaborative European observational cohort study.

Journal: EULAR rheumatology open
Published: June 29, 2026

Overall and Sex-Specific Predictors of Secukinumab Effectiveness in European Patients With Psoriatic Arthritis: Results From the EuroSpA Collaboration.

Overall and Sex-Specific Predictors of Secukinumab Effectiveness in European Patients With Psoriatic Arthritis: Results From the EuroSpA Collaboration.

Journal: The Journal of rheumatology
Published: June 15, 2026

Overall and sex-specific predictors of secukinumab effectiveness in European patients with psoriatic arthritis: results from the EuroSpA collaboration.

Overall and sex-specific predictors of secukinumab effectiveness in European patients with psoriatic arthritis: results from the EuroSpA collaboration.

Journal: The Journal of rheumatology
Published: June 15, 2026

Title Not Found

Title Not Found

Journal: Ugeskrift for laeger
Published: June 09, 2026

Site-specific articular response to TNF inhibitor in axial spondyloarthritis: a European cohort study.

Site-specific articular response to TNF inhibitor in axial spondyloarthritis: a European cohort study.

Journal: Joint bone spine
Published: May 13, 2026

Site-specific articular response to TNF inhibitor in axial spondyloarthritis: A European cohort study.

Site-specific articular response to TNF inhibitor in axial spondyloarthritis: A European cohort study.

Journal: Joint bone spine
Published: May 13, 2026

Role of MRI-based synthetic CT and low-dose CT for the assessment of structural damage in axial spondyloarthritis - a review.

Role of MRI-based synthetic CT and low-dose CT for the assessment of structural damage in axial spondyloarthritis - a review.

Journal: Joint bone spine
Published: May 01, 2026

How do individual monosodium urate depositions respond to urate-lowering therapy? A systematic evaluation using the dual-energy computed tomography modality.

How do individual monosodium urate depositions respond to urate-lowering therapy? A systematic evaluation using the dual-energy computed tomography modality.

Journal: Rheumatology (Oxford, England)
Published: May 01, 2026
Showing 1-12 of 479

Last Updated: 09/26/2026